Revolution Medicines (RVMD) Other financing activities (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Other financing activities of $12.2 million for Q1 2026, up 1220800.0% year-over-year from N/an in Q1 2025, and down 13.78% quarter-over-quarter from $14.2 million in Q4 2025.
Revolution Medicines (RVMD) Other financing activities (2019 - 2026) Analysis & Trends
Revolution Medicines' Other financing activities history runs 8 years deep, the most recent figure standing at $12.2 million for Q1 2026.
- In Q1 2026, Other financing activities rose 1220800.0% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $33.3 million (down 65.06% YoY), while the FY2025 annual figure was $21.1 million, down 77.85% from the prior year.
- Other financing activities for Q1 2026 stood at $12.2 million, down from $14.2 million in the prior quarter.
- The five-year high for Other financing activities was $87.3 million in Q4 2024, with the low at -$2.0 million in Q4 2023.
- The 5-year median for Other financing activities is $894000.0 (2022), against an average of $8.1 million.
- The sharpest annual moves came in 2023 and 2026: Other financing activities tumbled 354.57% in 2023, then surged 1220800.0% in 2026.
- Revolution Medicines' Other financing activities stood at $777000.0 in 2022, then sank by 354.57% to -$2.0 million in 2023, then soared by 4512.08% to $87.3 million in 2024, then plunged by 83.77% to $14.2 million in 2025, then declined by 13.78% to $12.2 million in 2026.
- Business Quant data shows RVMD's Other financing activities at $12.2 million in Q1 2026, $14.2 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.84 Mn |
| Jun 30, 2026 | 28.84 Mn |
| Mar 31, 2026 | 12.21 Mn |
| Mar 31, 2026 | 12.21 Mn |
| Dec 31, 2025 | 14.16 Mn |
| Dec 31, 2025 | 14.16 Mn |
| Sep 30, 2025 | 4.15 Mn |
| Sep 30, 2025 | 4.15 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 87.27 Mn |
| Dec 31, 2024 | 87.27 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Dec 31, 2023 | -1.98 Mn |
| Dec 31, 2023 | -1.98 Mn |